A comprehensive guide to the best healthcare stocks

• Healthcare is one of the largest and most resilient sectors in the global economy, seen as one of the only defensive sectors which still allow solid growth.
• The sector is remarkably diverse, spanning pharmaceutical companies, healthcare services providers, biotechnology, and medical equipment providers. The nature of these companies strongly dictates their growth potential, as well as their volatility.
• When weighing up which healthcare stocks to buy, the factors that matter most are growth prospects, financial strength, valuation, and dividends.

Healthcare is one of the largest and most resilient sectors in the global economy. It spans companies that develop and sell drugs, build medical devices, run hospitals, and provide health insurance, and it is worth trillions of dollars worldwide.
 
In an economic downturn, people will cut spending on going out, travelling, and shopping, but they rarely cut down on their healthcare spending. At the same time, technological advancements allow the possibility of treating diseases we previously were unable to treat. These two factors in conjunction are very rare – and cause healthcare to be seen as one of the only defensive sectors which still allow solid growth.
 
The industry is also remarkably diverse. It includes everything from century-old pharmaceutical giants paying steady dividends to early-stage biotech firms chasing a single breakthrough therapy. That mix means both short-term and long-term traders can usually find something that fits their approach. When you are weighing up which healthcare stocks to buy, the factors that matter most are growth prospects, financial strength, valuation, and dividends, and a solid grasp of risk management goes a long way before you commit any real capital.

Different types of healthcare stocks

When traders discuss healthcare stocks, they usually divide them into a few broad subgroups:

• Pharmaceutical companies
• ​Healthcare services providers
• Biotechnology companies
• Medical equipment providers

Each group behaves a little differently. Investing in large pharmaceutical firms is generally seen as lower risk thanks to their scale, diversified drug portfolios, and stable cash flows. This tends to translate into less volatile behaviour, with a lower average true range. This is especially true when you compare big-pharma names to young, new companies whose entire revenue depends on one drug.

Healthcare services providers and insurers also tend to be large, relatively stable companies, although they are heavily exposed to regulation and government policy. Biotechnology companies sit at the other end of the spectrum: many are newer to the market and carry higher risk, but they also offer some of the strongest growth potential in the sector, particularly when a clinical trial succeeds or a therapy wins approval.

To see how these different business models work in practice, it helps to look at some of the companies that have come to define each segment.

Eli Lilly

Eli Lilly is one of the world's most valuable pharmaceutical companies and a useful example of how innovation drives valuation in this space. Founded in the 19th century, it has a long history of medical firsts and today is best known for its work in diabetes, obesity, and weight-loss treatments. Its scale, deep research pipeline, and exposure to high-demand therapeutic areas are exactly the qualities long-term investors tend to look for in a large-cap pharma stock.

Johnson & Johnson

Johnson & Johnson is one of the most diversified names in healthcare, which is a big part of its appeal. Its business spans two main segments: Innovative Medicine, which develops prescription drugs, and MedTech, which manufactures medical devices. That diversification helps smooth out the impact of any single product setback and supports a long track record of dividend payments, making it a defensive healthcare holding.

Amgen

When discussing the fastest-growing corner of healthcare, biotech, Amgen is one of the pioneers. Founded in 1980, it has grown into a global biotechnology and pharmaceutical company with a presence in around 100 countries. Its inclusion in the Dow Jones Industrial Average reflects both the company's own standing and the wider importance of the biotech industry. Because biotech is considered one of the most innovation-driven segments, established players like Amgen are often viewed as a more stable way to gain exposure to it.

UnitedHealth Group

Insurance is a huge part of the healthcare industry, and UnitedHealth Group is one of the largest names in the managed care segment. Its strength has historically come from diversification across insurance and health services. The trade-off is sensitivity to regulation: managed care companies are directly exposed to government policy, reimbursement rates, and political events, which can move their share prices sharply in either direction. Also as a healthcare insurer, the firm is at the same time both a finance and healthcare company, this combination introduces new factors that influence stock prices, such as an increased sensitivity to interest rates.

Stryker

When it comes to medical devices and surgical robotics, Stryker is one of the recognised leaders. The company focuses heavily on orthopaedic and spinal procedures, an area where demand tends to rise steadily as populations age. Medical device makers like Stryker illustrate how some healthcare companies grow less through dramatic breakthroughs and more through consistent demand for essential equipment.

Teladoc Health

Teladoc Health is a well-known name in telemedicine, delivering healthcare services remotely over the phone and online. It represents a newer, more growth-oriented part of the services segment. The long-term shift towards digital health and remote care is a structural trend that continues to shape demand for companies operating in this space, though these stocks can be more volatile than established providers.

How do you choose the best healthcare stocks?

When you are deciding which healthcare stocks to buy, a handful of factors deserve most of your attention. The first is the company's growth prospects, and the second is its financial strength.
Combining technical analysis of the price action with fundamental analysis of the business is usually enough to give you a well-rounded view before investing.

Valuation is the next thing to check, so that you are confident you are paying a fair price. One of the most popular metrics here is the price-to-earnings, or P/E, ratio, which compares the company's share price to its earnings. By extension, it indicates how many years of current profits it would take to recoup your original investment.

Dividends are a big piece of the puzzle. Many healthcare stocks, especially the larger pharmaceutical firms, pay reliable and growing dividends. These can boost your overall returns and are a big reason healthcare dividend stocks remain popular as they create a form of regularly occurring income.

Risks of investing in healthcare stocks

Investing in healthcare stocks does come with several risks. It is a highly competitive market, and when a rival develops a better drug or product, sales can suddenly take a strong dive, which results in volatile earnings.

Regulation is the other major risk. Healthcare is one of the most heavily regulated sectors anywhere, and changes to government policy, drug pricing, or reimbursement rules can dramatically alter the outlook for individual stocks, particularly insurers and drug manufacturers. Patent expirations and clinical-trial failures are further sources of sharp, company-specific moves.

Despite these risks, the long-term outlook for the sector tends to remain solid. Perhaps its biggest advantage is that it has something for everyone: whether you are a long-term investor or you are hunting for the best small-cap healthcare stocks, you can find a fit in this market.